From: Cells of the synovium in rheumatoid arthritis. T lymphocytes
Molecule produced | Cell source | Major functional effects | Reference |
---|---|---|---|
IL-1β | FLS, Mono/Mac, Chond/OC | Inflammation, fever, synergy with IL-17 | [52,53,55,58] |
IL-6 | FLS, Mono/Mac, Chond/OC | Acute-phase reaction, B-cell stimulation, Th17 differentiation | [51-53,58] |
IL-23 | FLS | Inflammation, Th 17 cell stimulation | [56] |
TNF-α | Mono/Mac | Inflammation, synergy with IL-17 | [52,53] |
CXCL1 (GRO-α) | FLS, Chond/OC | Leukocyte recruitment | [55,60] |
CXCL5 (LIX) | Chond/OC | Leukocyte recruitment | [60] |
CXCL8 (IL-8) | FLS | Leukocyte recruitment | [51-53,55] |
CCL2 (MCP-1) | FLS, Chond/OC | Leukocyte recruitment | [55,60] |
CCL20 (MIP-3α) | FLS | Leukocyte recruitment | [54] |
G-CSF | FLS | Granulopoiesis | [51] |
GM-CSF | FLS | Granulopoiesis | [51–53] |
VEGF | FLS, Chond/OC | Angiogenesis | [57,59] |
Cyclooxygenase-2 | FLS, Mono/Mac, Chond/OC | Inflammation | [52,58] |
Prostaglandin E2 | FLS, Mono/Mac, Chond/OC | Inflammation | [51–53] |
RANK/RANK ligand | Chond/OC | Osteoclastogenesis and bone resorption | [53] |
Nitric oxide | Chond/OC | Tissue destruction | [52,53,58] |
Matrix metalloproteinases | Mono/Mac, Chond/OC | Cartilage and tissue destruction | [53,60] |